Capricor Therapeutics Inc (CAPR) — Cash Flow Quality Index

Latest as of December 2017: -0.22x

Capricor Therapeutics Inc (CAPR) has a Cash Flow Quality Index of -0.22x as of December 2017. Operating cash flow of $-2.67 Million is below net income of $12.31 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of Capricor Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.22x
Operating CF / Net Income

Operating Cash Flow

$-2.67 Million
USD

Net Income

$12.31 Million
USD

Data as of

Dec 2017
Most recent filing

Capricor Therapeutics Inc Cash Flow Quality Index (2017–2017)

Historical Cash Flow Quality Index for Capricor Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Capricor Therapeutics Inc.

Annual Cash Flow Quality Index for Capricor Therapeutics Inc (2017–2017)

Year-by-year earnings quality comparison for Capricor Therapeutics Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
2017 -5.85x $-14.23 Million $2.43 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.